Individualisation of Voriconazole Antifungal Therapy Antifungal Therapy

NCT01887457 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

33

Enrollment

OTHER

Sponsor class

Stopped Transfer of management of study

Conditions

Immunocompromised Patient
Aspergillosis
Fusarium

Interventions

DRUG: VFEND

Sponsor

Brynn Chappell

Collaborators

[object Object]